Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Biovie Inc (BIVI)

Biovie Inc (BIVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
First Phosphate and BioVie Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV ACCESS Newswire - Fri Aug 14, 8:00AM CDT

ORLANDO, FL / ACCESS Newswire / August 14, 2026 / RedChip Companies will air interviews with First Phosphate Corp. (NASDAQ:PHOS)(CSE:PHOS)(OTCQX:FRSPF)(FSE:KD0) and BioVie Inc. (Nasdaq:BIVI) on the RedChip...

PHOS.CN : 2.3000 (-5.74%)
BIVI : 0.9644 (-17.57%)
PHOS : 16.49 (-6.89%)
FRSPF : 1.6500 (-5.71%)
New to The Street Show 766 Broadcasts Tonight at 6:30 PM ET on Bloomberg Television, Featuring BioVie's Bezisterim Parkinson's Disease Clinical Results ACCESS Newswire - Sat Aug 8, 11:00AM CDT

Sponsored Programming Also Broadcasts Across Bloomberg Television in Latin America and MENA, Expanding the Global Reach of New to The Street's Featured Companies

CAST : 2.1000 (+144.24%)
RHNO : 8.0000 (+10.34%)
IGC : 0.2844 (+1.57%)
BIVI : 0.9644 (-17.57%)
VTIX : 1.5900 (-5.92%)
LTRN : 2.52 (-3.08%)
BSIN : 1.3900 (-2.11%)
DVLT : 0.3867 (+20.73%)
COCH : 0.7389 (+0.53%)
Join Biovie's Exclusive Live Investor Webinar: Inside the SUNRISE-PD Topline Results ACCESS Newswire - Fri Aug 7, 8:00AM CDT

BioVie CEO Cuong Do to discuss the newly released Phase 2 SUNRISE-PD results and what they mean for the future development of bezisterim in Parkinson's disease

BIVI : 0.9644 (-17.57%)
BioVie Announces Topline Results of Phase 2 SUNRISE-PD Trial of Bezisterim in Early Parkinson’s Disease GlobeNewswire - Thu Aug 6, 6:30AM CDT

Patients treated with bezisterim demonstrated statistically significant improvements compared to placebo on both motor and non-motor symptoms, as assessed by MDS-UPDRS 1 Parts I, II, and III, as well...

BIVI : 0.9644 (-17.57%)
Did BioVie Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire - Fri Jun 5, 2:31PM CDT

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible...

BIVI : 0.9644 (-17.57%)
Foremost Clean Energy and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV ACCESS Newswire - Fri May 29, 4:00AM CDT

ORLANDO, FL / ACCESS Newswire / May 29, 2026 / RedChip Companies will air interviews with Foremost Clean Energy Ltd. (Nasdaq:FMST)(CSE:FAT) and BioVie, Inc. (Nasdaq:BIVI) on the RedChip Small Stocks, Big...

BIVI : 0.9644 (-17.57%)
FMST : 1.1400 (-4.20%)
FAT.CN : 1.5500 (-7.74%)
Join BioVie’s Exclusive Live Investor Webinar and Q and A Session on June 2 GlobeNewswire - Wed May 27, 7:00AM CDT

CARSON CITY, Nev., May 27, 2026 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and...

BIVI : 0.9644 (-17.57%)
BioVie Announces Full Enrollment of the ADDRESS-LC Trial of Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID GlobeNewswire - Tue May 26, 7:00AM CDT

-Topline Data Release Targeted Late Summer 2026- CARSON CITY, Nev., May 26, 2026 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing...

BIVI : 0.9644 (-17.57%)
BioVie Announces Completion of Phase 2 SUNRISE-PD Trial in Early-Stage Parkinson’s Disease GlobeNewswire - Mon May 18, 7:00AM CDT

CARSON CITY, Nev., May 18, 2026 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and...

BIVI : 0.9644 (-17.57%)
BioVie to Host Virtual KOL Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Parkinson's Disease ahead of Topline Data in 2Q26, on May 7, 2026 GlobeNewswire - Mon Apr 27, 7:00AM CDT

CARSON CITY, Nev., April 27, 2026 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and...

BIVI : 0.9644 (-17.57%)

Barchart Exclusives

LHX Stock in Focus as L3Harris Technologies Ousts CEO Barchart - Tue Aug 18, 4:07PM CDT
L3Harris ousts CEO Christopher Kubasik and names Sam Mehta as new chief executive. Here’s what the leadership change really means for LHX shares. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.